Citation: H. Huland et al., PREOPERATIVE PREDICTION OF TUMOR HETEROGENEITY AND RECURRENCE AFTER RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATIC-CARCINOMA WITH DIGITAL RECTAL EXAMINATION, PROSTATE-SPECIFIC ANTIGEN AND THE RESULTS OF 6 SYSTEMATIC BIOPSIES, The Journal of urology, 155(4), 1996, pp. 1344-1347
Citation: H. Huland, UP-FRONT INTRAVESICAL CHEMOTHERAPY FOR LOW STAGE, LOW-GRADE RECURRENTBLADDER-CANCER - EDITORIAL COMMENT, The Journal of urology, 155(1), 1996, pp. 93-93
Citation: P. Hammerer et H. Huland, IMPORTANCE OF PSA DETERMINATION IN EARLY IDENTIFICATION OF CARCINOMA OF THE PROSTATE, Der Urologe, 34(4), 1995, pp. 283-289
Authors:
HAMMERER P
HUBNER D
GONNERMANN D
HULAND H
Citation: P. Hammerer et al., PERIOPERATIVE AND POSTOPERATIVE COMPLICAT IONS IN PELVIC LYMPHADENECTOMY AND RADICAL PROSTATECTOMY IN 320 CONSECUTIVE PATIENTS, Der Urologe, 34(4), 1995, pp. 334-342
Authors:
GROSS AJ
HUBNER D
MEYERMOLDENHAUER WH
HULAND H
Citation: Aj. Gross et al., THE TREATMENT OF RECTAL INJURIES INCLUDIN G VESICORECTAL FISTULAS IN RADICAL PROSTATECTOMIES, Der Urologe, 34(1), 1995, pp. 43-45
Citation: J. Noldus et al., AUTOLOGOUS BLOOD-TRANSFUSION IN RADICAL PROSTATECTOMY - RESULTS IN 263 PATIENTS, European urology, 27(3), 1995, pp. 213-217
Citation: H. Huland et P. Hammerer, IS A PREDICTION OF NEGATIVE MARGINS AND CONTINENCE POSSIBLE BEFORE RADICAL PROSTATECTOMY, European urology, 27, 1995, pp. 28-31
Citation: E. Huland et al., IN-VIVO SYSTEM TO DETECT LONG-TERM CONTINUOUS RELEASE OF BIOACTIVE INTERLEUKIN-2 BY IMMUNOPHARMACOLOGICAL DEPOT PREPARATIONS IN NUDE-MICE WITH HUMAN TUMORS, Journal of cancer research and clinical oncology, 121(5), 1995, pp. 285-290
Authors:
SCHWAIBOLD H
HULAND E
HEINZER H
SCHWULERA U
HULAND H
Citation: H. Schwaibold et al., TOXICITY OF LOCAL, CONTINUOUS AND CYCLIC, HIGH-DOSE BLADDER PERFUSIONWITH RECOMBINANT AND NATURAL INTERLEUKIN-2 IN ADVANCED CANCER OF THE URINARY-BLADDER, Journal of cancer research and clinical oncology, 121(4), 1995, pp. 239-246
Citation: E. Huland et al., LONG-TERM MONITORING OF 486P-3 12-ANTIGEN PATTERN (QUANTITATIVE IMMUNOCYTOLOGY) BEFORE, DURING, AND AFTER MITOMYCIN-C PROPHYLAXIS IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER/, Urology, 45(1), 1995, pp. 54-57
Citation: H. Huland, LONG-TERM MONITORING OF 486P-3 12-ANTIGEN PATTERN (QUANTITATIVE IMMUNOCYTOLOGY) BEFORE, DURING, AND AFTER MITOMYCIN-C PROPHYLAXIS IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER - REPLY/, Urology, 45(1), 1995, pp. 58-58
Authors:
NICOLAS V
BEESE M
KEULERS A
BRESSEL M
KASTENDIECK H
HULAND H
Citation: V. Nicolas et al., MRI IN PROSTATE CARCINOMA CONVENTIONAL VE RSUS ENDORECTAL SURFACE COIL MRI, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 161(4), 1994, pp. 319-326
Citation: H. Schwaibold et al., LONG-TERM FOLLOW-UP OF CYTOSTATIC INTRAVE SICAL INSTILLATION USING MITOMYCIN-C AND ADRIAMYCIN IN PATIENTS WITH SUPERFICIAL BLADDER-CARCINOMA, Der Urologe, 33(6), 1994, pp. 479-483
Citation: D. Hubner et al., MORPHOLOGIC RESULTS OF 106 CONSECUTIVE RA DICAL PROSTATECTOMY SPECIMENS FROM PATIENTS WITH CLINICAL STAGE-B1-B3 (T2A-C) AND HISTOLOGIC NEGATIVE LYMPH-NODES IN THE FOSSA-OBTURATORIA, Der Urologe, 33(6), 1994, pp. 497-504
Authors:
CONRAD S
SCHNEIDER AW
GONNERMANN D
GANAMA A
TENSCHERT W
HULAND H
Citation: S. Conrad et al., UROLOGICAL COMPLICATIONS IN RENAL-TRANSPL ANTATION - EXPERIENCE WITH 539 CONSECUTIVE RECIPIENTS IN A SINGLE-CENTER, Der Urologe, 33(5), 1994, pp. 392-400
Authors:
NOLDUS J
ANCKER U
SCHAFER H
CONRAD S
HULAND H
Citation: J. Noldus et al., MULTICENTRIC AND LARGE ANGIOMYOLIPOMA OF THE KIDNEY, ADRENAL-GLAND AND PARAAORTIC LYMPH-NODES - CASE-REPORT OF A 9-YEAR-OLD BOY WITH TUBEROUS SCLEROSIS, Der Urologe, 33(5), 1994, pp. 453-456